Brief: Edgewise Therapeutics Q2 Operating Expenses USD 38.107 Million
08/08/2024 13:00
Aug 08 (Reuters) - Edgewise Therapeutics Q2 basic EPS USD -0.34. * Q2 net income USD -31.497 million * Q2 operating income USD -38.107 million
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending